This article is for men with metastatic castration-resistant prostate cancer (mCRPC) whose PSMA-PET scan shows PSMA-positive disease. If you are considering lutetium Lu-177 vipivotide tetraxetan - called Pluvicto - and cost is a barrier to treatment, this guide covers the financing options that international patients have used when coming to India for care.
Short answer: Most international patients finance Lu-177 PSMA therapy in India through a personal medical loan arranged in their home country, a staged payment plan with the Indian hospital, or reimbursement through an employer health or occupational benefit. Many patients combine two or more of these to cover a full course, which typically runs four to six cycles spaced six to eight weeks apart.
How Does Lu-177 PSMA Therapy Cost Compare in India vs the US?
The cost gap between India and the United States is why most international patients make the trip. In the US, the drug alone - lutetium Lu-177 vipivotide tetraxetan (Pluvicto) - costs roughly USD 42,500 to 49,989 per cycle according to the Drugs.com price guide. A standard six-cycle course can exceed USD 250,000, before hospital fees, physician charges, or the PSMA-PET scan needed for eligibility are added. For patients from the GCC, Africa, or South Asia without comprehensive coverage, that amount is not realistic.
In India, the same therapy costs far less. Domestic radiopharmaceutical manufacturing keeps input costs lower than in markets relying on imported supplies. Exact pricing varies by hospital, city, and care package. Always request a written all-in cost estimate that breaks down the drug cost, administration fee, blood work, and imaging before making any commitments.
| Cost factor | India (2025 approx.) | USA - Pluvicto (2024-2025) |
|---|---|---|
| Drug cost per cycle (USD) | Varies by hospital and city; request a written quote | approx. USD 42,500-49,989 per cycle |
| Full 6-cycle course (USD) | Varies by hospital; request a written quote | approx. USD 255,000 or more |
| PSMA-PET eligibility scan | Varies by hospital; request a written quote | Varies by facility; contact the treating center |
| Typical payment method | Self-pay, medical loan, or employer reimbursement | Insurer-direct with prior authorisation; high out-of-pocket if uninsured |
US per-cycle drug cost from the Drugs.com Pluvicto price guide (accessed 2025). Full-course US estimate is derived from six cycles at the per-cycle drug price. India pricing varies considerably by hospital and care package; confirm all figures directly with the treating centre before any financial planning.
Even after flights, accommodation, and a companion across multiple trips, the total cost in India is typically much less than the US drug list price alone. A detailed breakdown appears in our article on Lu-177 PSMA therapy cost in India vs the US.
Confirm Eligibility Before You Arrange Any Financing
There is no point getting a loan or sending a deposit until you know you are a candidate. Lutetium Lu-177 vipivotide tetraxetan works by binding to PSMA, a protein on the surface of prostate cancer cells. If your recent PSMA-PET scan does not show enough PSMA uptake, the therapy is unlikely to help you - and a reputable centre will say so rather than proceed.
Before any financial commitment, you can request a Lu-177 eligibility review through Art of Healing Cancer, the clinical partner behind this site. Share your recent PSMA-PET scan report, your PSA trend over the past six to twelve months, and a summary of your treatment history. The team can assess whether the imaging supports eligibility and what a realistic treatment plan looks like. If you are not a candidate, they can discuss other options for your case. Knowing you are eligible first makes sure every financing step that follows is worth your time and money.
Option 1 - Medical Tourism Loans from Your Home Country
A medical tourism loan is a personal loan from a bank, credit union, or specialist lender in your home country to cover care abroad. This option is available in many markets that send patients to India, including the UAE, Saudi Arabia, Nigeria, Kenya, Bangladesh, and Sri Lanka.
How these loans typically work:
- You apply through your existing bank or a specialist lender.
- Most lenders require a formal cost estimate from the Indian hospital before approving the loan amount.
- Loan amounts can cover the treatment cost, flights, and accommodation.
- Repayment periods commonly range from two to five years.
- Interest rates vary by country, lender, and your credit history.
What you typically need to apply:
- A written itemised cost estimate from the Indian hospital, broken down per cycle.
- A letter from your oncologist confirming that this treatment is medically recommended.
- Standard proof of identity and income, as required by any lender.
The Indian hospital will prepare an estimate letter on request - use this in your loan application. Some patients from the GCC approach their existing bank, which may offer a dedicated medical loan product. Patients from West Africa and East Africa have used cooperative societies, microfinance institutions, and employer salary advance schemes alongside personal savings.
Consider this carefully: interest-bearing loans cost more over time. If you are also considering an employer reimbursement claim (see Option 3 below), factor in the total repayment amount over the loan term, not just the monthly payment.
Option 2 - Hospital Payment Plans in India
Many hospitals in India that offer Lu-177 PSMA therapy work with international patients and can structure billing across your treatment course. The arrangement usually works in stages:
- A deposit - often 30 to 50 percent of the estimated total - is paid before arrival to secure your bed, your radiopharmaceutical slot, and your admission date.
- The remaining balance is settled at or after each cycle, or at final discharge.
- Some hospitals will spread payments across cycles for patients completing a multi-cycle course over several months.
Payment plans are negotiated directly with the hospital's international patient services department. When you contact them, ask exactly what is included in the per-cycle estimate and what may be billed separately - for example, additional blood tests, supportive medications during the admission, or follow-up imaging.
One practical note: lutetium Lu-177 vipivotide tetraxetan is prepared specifically for each patient and cannot be reused. Most hospitals require the deposit before the radiopharmaceutical is ordered. You need the deposit amount available well before your travel date, not on arrival. Plan your cash flow from the start.
Option 3 - Employer Health and Occupational Benefits
If you are still employed - or if the family member managing costs is employed - check the health or occupational benefit attached to that job. Many international patients forget to check their employer's health plan.
Some employer health plans, particularly in the GCC countries (UAE, Saudi Arabia, Qatar, Kuwait, Oman), include a referral-abroad benefit. This allows employees to seek treatment in another country when the required therapy is not available locally, or when local access is significantly delayed. Lu-177 PSMA therapy is not widely available across the GCC at the same scale as in India, which may support a referral-abroad request under some plans.
Steps to check whether your employer scheme covers international treatment:
- Read the policy document for terms like "referral abroad," "treatment overseas," or "international benefit."
- Ask your HR department whether a prior-authorisation process exists for treatment in another country.
- Get a letter from your oncologist confirming that the treatment is medically necessary and is not available locally on equivalent terms.
- Submit the Indian hospital estimate alongside the oncologist letter as part of the authorisation request.
- Ask whether partial reimbursement is available if the plan does not cover the full amount.
Allow four to eight weeks for the authorisation process. Partial reimbursement is still meaningful - even covering flights and accommodation reduces your total out-of-pocket cost significantly. If your insurer at home has already denied coverage, the article on insurance coverage and appeals for Lu-177 PSMA therapy covers the appeals process and the documentation that reviewers find most convincing.
Option 4 - Other Sources of Funding
Most patients who travel to India for treatment combine more than one funding source. Here are four additional channels worth exploring alongside the main options above.
Family pooling. In many cultures across South Asia, Africa, and the GCC, extended families pool resources for major medical expenses. A clear written breakdown of expected costs per cycle - covering the treatment estimate, flights, and accommodation - helps family members understand the commitment and reduces ambiguity about who contributes what.
Medical crowdfunding. Platforms used by cancer patients include GoFundMe (widely used in the US, UK, Canada, and Australia), Milaap (India), and Ketto (India). A campaign that is medically specific and transparent tends to generate more donor trust. Include your diagnosis, scan findings, and the name of the therapy so donors understand exactly how the funds will be used.
Retirement savings and fixed deposits. Some patients draw on provident fund balances, retirement accounts, or fixed deposits. Check the tax implications in your home country before withdrawing. Early withdrawal from some accounts carries penalties that reduce the net amount available.
Prostate cancer foundations. The Prostate Cancer Foundation publishes resources on financial assistance programs for patients with advanced prostate cancer. Eligibility criteria vary and many programs are limited to residents of specific countries, but check what is available in your country of residence.
How to Sequence Your Financing Plan
Financing a full course of therapy is easier when you work through it in a clear order. Here is a practical sequence that has helped other patients coming from overseas.
- Confirm eligibility first. Share your PSMA-PET scan with the treating team. No financing step is worth taking until you know you are a candidate.
- Request a written all-in cost estimate from the hospital. Ask for a per-cycle breakdown so you can plan each cycle's costs separately and know exactly what is included.
- Start the employer authorisation process early. Allow four to eight weeks. Begin the paperwork while you are still gathering quotes and confirming eligibility.
- Identify your primary funding channel. Personal loan, employer reimbursement, family savings, or a combination. Write it down so you can track each source against the amount needed.
- Build a contingency buffer. Some patients need an extra cycle beyond the initial plan. Budgeting for one additional cycle at the outset avoids a financial crisis if that happens.
- Plan your travel budget separately. Flights, accommodation per cycle, a companion's costs, and local transport add up across multiple trips. Our guide on planning your India trip for Lu-177 PSMA therapy covers realistic travel cost expectations that many patients do not factor in at the start.
When to Talk to Your Doctor
Talk to your oncologist before committing to any financing arrangement. You need to know whether Lu-177 PSMA therapy is appropriate for your specific case at this point in your treatment history, how many cycles are realistically expected, and whether any other therapy should be considered alongside or instead of it. If your oncologist has not yet discussed this option, ask specifically whether a PSMA-PET scan has been done and whether you may be a candidate. The FDA approved lutetium Lu-177 vipivotide tetraxetan (Pluvicto) for PSMA-positive mCRPC in March 2022, and it is now available at specialist nuclear medicine centres in India. You can submit your scans for an eligibility review or ask about alternatives through the Lutetium Therapy contact form.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.
Frequently asked questions
Can I get a medical loan for Lu-177 PSMA treatment in India if I live outside India?
Yes. Most patients arrange a personal or medical loan through a bank or lender in their home country rather than through an Indian institution. You will typically need a written cost estimate from the Indian hospital, a letter from your oncologist confirming medical necessity, and standard proof of income and identity. Interest rates and loan terms vary by country and lender. Some banks in the GCC and South Asia offer dedicated medical loan products that suit this purpose well.
How much of a deposit do Indian hospitals typically require before treatment starts?
Most hospitals that treat international patients ask for a deposit of 30 to 50 percent of the estimated total cost before your arrival. This deposit covers the reservation of your treatment slot and allows the hospital to order the radiopharmaceutical, which is prepared specifically for each patient and cannot be reused once prepared. The balance is usually settled at the end of each cycle or at final discharge. Confirm the exact deposit amount and payment schedule with the international patient services team well before you book travel.
Will my home-country insurance cover Lu-177 PSMA therapy received in India?
It depends on your specific policy. Many domestic health insurance plans do not cover routine treatment overseas, but some employer health plans in the GCC and other markets include a referral-abroad benefit for treatments not available locally. Check your policy for terms like 'treatment abroad' or 'international referral' and ask your HR department whether a prior-authorisation process exists. Even if the plan does not cover the full cost, partial reimbursement is worth pursuing and can meaningfully reduce your out-of-pocket total.
Do I need to travel to India for every cycle of Lu-177 PSMA therapy?
Lutetium Lu-177 vipivotide tetraxetan must be administered in a specialist nuclear medicine facility licensed to handle this radiopharmaceutical. If that facility is in India and the therapy is not available in your home country, you will need to travel for each cycle. Cycles are typically spaced six to eight weeks apart. Some patients stay in India for the full course; others return home between cycles. Each approach has different cost and logistics implications that are worth planning well in advance.
What documents do I need to apply for a medical tourism loan for treatment in India?
Most lenders require a written itemised cost estimate from the Indian hospital, a letter from your oncologist confirming the diagnosis and treatment recommendation, proof of identity, and income documentation. Some lenders may also request a copy of your PSMA-PET scan report or a summary of your treatment plan. The hospital's international patient services team can prepare the estimate letter in a format suitable for loan applications.
Is it worth combining a personal loan with an employer reimbursement claim?
Yes, in many cases. You can take a personal loan to pay the hospital upfront and then use any employer reimbursement received later to repay part of the loan ahead of schedule. This reduces the total interest you pay. The key is to submit the employer authorisation request as early as possible - ideally at the same time you are gathering hospital quotes - so the reimbursement timeline is as short as possible.
